Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space

Anaesthesia

Volumn 62, Issue 6, 2007, Pages 575-580

  Fukada, Tom ^a   Ozaki, M ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; LIPID; MARUISHI; PROPOFOL; UNCLASSIFIED DRUG;

ARTICLE; ASEPSIS; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ESCHERICHIA COLI; GROWTH INHIBITION; HEALTH CARE PERSONNEL; IN VITRO STUDY; INFECTION; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MEDICAL INSTRUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL GROWTH; NONHUMAN; OCCUPATIONAL EXPOSURE; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; VASCULAR ACCESS;

ANESTHETICS, INTRAVENOUS; BACTERIA; CHEMISTRY, PHARMACEUTICAL; CROSS INFECTION; DRUG CONTAMINATION; DRUG DELIVERY SYSTEMS; EDETIC ACID; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; HUMANS; PROPOFOL;

EID: 34249056453     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05002.x     Document Type: Article

References (12)

1. Berry CB, Gillespie T, Hood J, Scott NB. Growth of micro-organisms in solutions of intravenous anesthetic agents. Anaesthesia 1993; 48: 30-2.
2. Tessler M, Dascal A, Gioseffini S, Miller M, Mendelson J. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media. Canadian Journal of Anaesthesia 1992; 39: 509-11.
3. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesthesia and Analgesia 1993; 77: 766-8.
4. Langevin PB, Gravenstein N, Doyle TJ, et al. Growth of Staphylococcus aureus in Diprivan and Intralipid: Implications on the pathogenesis of infections. Anesthesiology 1999; 91: 1394-400.
5. Jones C. Fundamentals of emulsions. American Journal of Anesthesiology 2000; 27 (Suppl.): 12-5.
6. Goldmann D, Pier GB. Pathogenesis of infections related to intravascular catheterization. Clinical Microbiology Reviews 1993; 6: 176-92.
7. Bennett SN, McNail MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. New England Journal of Medicine 1995; 333: 147-54.
8. Webb SA, Robert B, Breheny FX, et al. Contamination of propofol infusions in the intensive care unit: Incidence and clinical significance. Anaesthesia and Intensive Care 1998; 26: 162-4.
9. Farrington M, McGinnes J, Matthews I, Park GR. Do infusions of midazolam and propofol pose an infection risk to critically ill patients? British Journal of Anaesthesia 1994; 72: 415-7.
10. Bach A, Motsch J, Schmidt H, et al. In-use contamination of propofol. A clinical study. European Journal of Anaesthesiology 1997; 14: 178-83.
11. Boyce JM, Pittet D. Guidelines for hand hygiene in health-care settings recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. Morbidity and Mortality Weekly Report 2002; 51 (RR-16): 1-45.
12. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 2002; 51 (RR-10): 1-29.